Veracyte is trading 4.38% higher at $47.42 on September 28, 2026, with no clear company-specific catalyst identified for the move. - The latest reported company news was a September 26 announcement about eight Decipher-focused studies planned for ASTRO 2026; it does not establish a connection to today’s rise. - Broad markets are lower, but supplied index declines are under 0.5%; available evidence does not indicate a clear market-driven explanation. - Trading volume and activity details were unavailable.